Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab.

Trial Profile

Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 May 2017

At a glance

  • Drugs RIX 4414 (Primary)
  • Indications Rotavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2017 Planned number of patients changed from 4550 to 10210.
    • 01 Apr 2017 Results published in the PLOS Medicine
    • 27 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top